Literature DB >> 8830793

Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro.

L L Xu1, M K Warren, W L Rose, W Gong, J M Wang.   

Abstract

Because dendritic cells (DC) are the most potent antigen-presenting cells involved in many pathophysiological responses, we investigated the effect of chemokines on the migration of these cells in an effort to determine whether chemokines may contribute to the initiation of immune responses. CD34+ progenitor cells isolated from umbilical cord blood were grown in suspension cultures with cytokines and expanded 50- to 100-fold. A variable proportion of the cells expressed markers consistent with DC. The proportion of CD1a+ DC was increased when the cells were cultured with interleukin-4 (IL-4). These cells expressed specific binding sites for C-C and C-X-C chemokines. Cells cultured with or without IL-4 had similar binding profiles. All C-C chemokines tested, including monocyte chemotactic protein (MCP)-1, MCP-2, MCP-3, macrophage inflammatory protein-1 alpha (MIP1 alpha), MIP-1 beta, and RANTES, induced migration of DC-enriched cells cultured with or without IL-4 with MCP-3 being the most potent chemoattractant. Phenotypic analysis of cell migrating in response to C-C chemokines showed that CD1a+ cells were indeed attracted across the polycarbonate filters, and there was no preferential attraction of contaminating CD14+ monocytes by C-C chemokines. DC-enriched cells also expressed specific binding sites for IL-8 and NAP2, which failed to induce cell migration. Our results suggest that C-C chemokines may participate in the recruitment of DC to amplify host defense.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8830793     DOI: 10.1002/jlb.60.3.365

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  122 in total

Review 1.  Chemokines and dendritic cell traffic.

Authors:  S Sozzani; P Allavena; A Vecchi; A Mantovani
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

2.  Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury.

Authors:  Jaime Emmetsberger; Stella E Tsirka
Journal:  Neurobiol Dis       Date:  2012-05-14       Impact factor: 5.996

3.  The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.

Authors:  Y Sassa; S Yoshida; K Ishikawa; R Asato; T Ishibashi; T Kono
Journal:  Eye (Lond)       Date:  2016-02-26       Impact factor: 3.775

4.  In vitro evaluation of TLR4 agonist activity: formulation effects.

Authors:  Ayesha Misquith; H W Millie Fung; Quinton M Dowling; Jeffrey A Guderian; Thomas S Vedvick; Christopher B Fox
Journal:  Colloids Surf B Biointerfaces       Date:  2013-09-19       Impact factor: 5.268

5.  Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.

Authors:  Tom J H Arends; Johannes Falke; Rianne J M Lammers; Diederik M Somford; Jan C M Hendriks; Mirjam C A de Weijert; Harm C Arentsen; Antoine G van der Heijden; Egbert Oosterwijk; J Alfred Witjes
Journal:  World J Urol       Date:  2014-12-10       Impact factor: 4.226

Review 6.  Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects.

Authors:  Carl N Sprung; Alesia Ivashkevich; Helen B Forrester; Christophe E Redon; Alexandros Georgakilas; Olga A Martin
Journal:  Cancer Lett       Date:  2013-09-14       Impact factor: 8.679

7.  The investigation of immunomodulatory activities of Gloeostereum incaratum polysaccharides in cyclophosphamide-induced immunosuppression mice.

Authors:  Di Wang; Qian Li; Yidi Qu; Mengya Wang; Lanzhou Li; Yang Liu; Yu Li
Journal:  Exp Ther Med       Date:  2018-01-30       Impact factor: 2.447

8.  A myristoylated alanine-rich C kinase substrate-related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils.

Authors:  Jingjing Li; Melissa A D'Annibale-Tolhurst; Kenneth B Adler; Shijing Fang; Qui Yin; Adam J Birkenheuer; Michael G Levy; Samuel L Jones; Eui Jae Sung; Eleanor C Hawkins; Jeffrey A Yoder; Shila K Nordone
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-06       Impact factor: 6.914

9.  Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation.

Authors:  Chien-Chi Lin; Patrick D Boyer; Alex A Aimetti; Kristi S Anseth
Journal:  J Control Release       Date:  2009-11-29       Impact factor: 9.776

10.  Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease.

Authors:  Stephen J Horgan; Chris J Watson; Nadia Glezeva; Pat Collier; Roisin Neary; Isaac J Tea; Niamh Corrigan; Mark Ledwidge; Ken McDonald; John A Baugh
Journal:  J Cardiovasc Transl Res       Date:  2015-11-17       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.